Candida perforation of the intestine in an HIV-exposed but uninfected infant

SAJCH South African Journal of Child Health

Volumn 8, Issue 3, 2014, Pages 119-121

  Hoffmann, Kelly S ^a   Green, Robin J ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Candida; HIV exposed; Infant; Intestinal perforation

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ABDOMINAL RADIOGRAPHY; ACUTE GASTROENTERITIS; ARTICLE; CANDIDA ALBICANS; CANDIDEMIA; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; EXPOSURE; FUNGUS GROWTH; FUNGUS HYPHAE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; INFANT; INTESTINE PERFORATION; INVASIVE CANDIDIASIS; MALE; NAPPY CANDIDIASIS; THRUSH; VIRUS TRANSMISSION;

EID: 84924255785     PISSN: 19943032     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAJCH.646     Document Type: Article

References (20)

1. Calderone RA, Fonzi, WA. Virulence factors of Candida albicans. Trends Microbiol 2001;9(7):327-335. [http://dx.doi.org/10.1016/S0966-842X(01)02094-7].
2. Jain A, Jain S, Rawat S. Emerging fungal infections among children: A review on its clinical manifestations, diagnosis and prevention. J Pharm Bioallied Sci 2010;2(4):314-320. [http://dx.doi.org/10.4103/0975-7406.72131].
3. Solgrove A, Reikie B, Naidaoo S, et al. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr 2012;58(6):505-508. [http://dx.doi.org/10.1093/tropej/fms019].
4. Jones CE, Naidoo S, de Beer C, et al. Maternal HIV infection and antibody response against vaccine preventable disease in uninfected infants. JAMA 2011;305(6):576-584. [http://dx.doi.org/10.1001/jama.2011.100].
5. Abramczuk B, Mazzola TN, Moreno YMF, et al. Impaired humoral response to vaccines among HIV-exposed uninfected infants. Clin Vaccine Immunol 2011;18(9):1406-1409. [http://dx.doi.org/10.1128/CVI.05065-11].
6. Borges-Almeida E, Milanez HMBPM, Vilela MMS, et al. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns. BMC Infect Dis 2011;11(3 Feb):38. [http:// dx.doi.org/10.1186/1471-2334-11-38].
7. Kuhn L, Meddows-Taylor S, Gray G, et al. Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero. Clin Infect Dis 2002;34(2):267-276. [http://dx.doi.org/10.1086/338153].
8. Faye A, Pornprasert S, Mary JY, et al. Characterisation of the main placental cytokine profiles from HIV-1 infected pregnant women treated with antiretroviral drugs in France. Clin Exp Immunol 2007;149(3):430-439. [http:// dx.doi.org/10.1111/j.1365-2249.2007.03411.x].
9. Bunders M, Pembrey L, Kuijpers T, et al. Evidence of impact of maternal HIV infection on immunoglobulin levels in HIV-exposed uninfected children. AIDS Res Hum Retroviruses 2010;26(9):967-975. [http://dx.doi.org/10.1089/ aid.2009.0241].
10. Bunders M, Thorne C, Newell ML, et al. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1 infected mothers. AIDS 2005;19(10):1071-1079. [http://dx.doi.org/10.1097/01. aids.0000174454.63250.22].
11. Moyes D, Naglik J. Mucosal immunity and Candida albicans infection. Clin Dev Immunol 2011;2011:346307. [http://dx.doi.org/10.1155/2011/346307].
12. Yan L, Yang C, Tang J. Disruption of the intestinal mucosal barrier in Candida albicans infections. Microbiol Res 2013;168(7):389-395. [http://dx.doi. org/10.1016/j.micres.2013.02.008].
13. Hacimustafaoglu M, Celebi S. Candida infections in non-neutropenic children after the neonatal period. Expert Rev Anti Infect Ther 2001;9(10):923-940. [http://dx.doi.org/10.1586/eri.11.104].
14. Feja KN, Wu F, Roberts, K, et al. Risk factors for candidemia in critically ill infants. J Pediatr 2005;147(2):156-161. [http://dx.doi.org/10.1016/j.peds.2005.02.021].
15. Chow JK, Golan Y, Ruthazer R, et al. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 2008;36(7):1993-1998. [http://dx.doi.org/10.1097/CCM.0b013e31816fc4cd].
16. Faure-Fontenla MA, Bracho-Blanchet E, Yañez-Molina C, Barragan-Tame L. Gastric perforation with Candida tropicalis invasion in a previously healthy girl. Mycoses 1997;40(5-6):175-177. [http://dx.doi.org/10.1111/j.1439-0507.1997.tb00210.x].
17. Mohanty S, Kini U. Candida intestinal perforation in a nonimmunocompromised infant. Indian Pediatr 2000;37(5):549-552..
18. Naglik J, Moyes D, Wächtler B, et al. Candida albicans interactions with epithelial cells and mucosal immunity. Microbes Infect 2011;13(12-13):963-976. [http://dx.doi.org/10.1016/j.micinf.2011.06.009].
19. Villar CC, Kashleva H, Mitchell AP, et al. Invasive phenotype of Candida albicans affects the host pro-inflammatory response to infection. Infect Immun 2005;73(8):4588-4595. [http://dx.doi.org/10.1128/IAI.73.8.4588-4595.2005].
20. Silvestri L, de la Cal M, van Saene H. Selective decontamination of the digestive tract: The mechanism of action is control of gut overgrowth. Intensive Care Med 2012;38(11):1738-1750. [http://dx.doi.org/10.1007/ s00134-012-2690-1].